Sandra Mullen, PharmD, BCPP

Sandra Mullen is a member of the College of Psychiatric and Neurologic Pharmacists and the American Society of Health Systems Pharmacists.

She serves as a CPNP Recertification Editorial Board Member and PGY2 Psychiatric Pharmacy Residency Program Director.

“Major depressive disorder in children and adolescents” Mullen S. Ment Health Clin. 2018;8(6):275-83.

© Mullen S. Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders. In: Ehret M, et al. CPNP Psychiatric Pharmacotherapy Review Course. 2018-2019 ed. Lincoln (NE): College of Psychiatric and Neurologic Pharmacists; 2018

“Psychiatric admission in adolescent transgender patients: a case series” Alastanos J, Mullen S. The Mental Health Clinician. 2017;7(4):172-5.

© Mullen S. Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders. In: Chavez, B, et al. CPNP Psychiatric Pharmacotherapy Review Course. 2016-2017 ed. Lincoln (NE): College of Psychiatric and Neurologic Pharmacists; 2016

© Al-Mateen A, Mullen S, Malloy J. Pharmacotherapy. In Alfiee M, et al. Handbook of Mental Health in African American Youth. Springer International Publishing, Switzerland. 2016

“Review of pediatric autoimmune neuropsychiatric disorder associated with streptococcal infections” The Mental Health Clinician, July 2015